Category: Despite Falling Drug Sales

Despite Falling Drug Sales, Johnson & Johnson Remains Optimistic

  1. Despite Falling Drug Sales, Johnson & Johnson Remains Optimistic  Motley Fool
  2. Johnson & Johnson’s (JNJ) CEO Alex Gorsky on Q2 2017 Results – Earnings Call Transcript  Seeking Alpha
  3. Johnson & Johnson Reports 2017 Second-Quarter Results:  PR Newswire (press release)
  4. Full coverage

from Business – Google News https://www.fool.com/investing/2017/07/18/despite-falling-drug-sales-johnson-johnson-remains.aspx

Advertisements

Despite Falling Drug Sales, Johnson & Johnson Remains Optimistic

  1. Despite Falling Drug Sales, Johnson & Johnson Remains Optimistic  Motley Fool
  2. Johnson & Johnson’s (JNJ) CEO Alex Gorsky on Q2 2017 Results – Earnings Call Transcript  Seeking Alpha
  3. Johnson & Johnson Reports 2017 Second-Quarter Results:  PR Newswire (press release)
  4. Full coverage

from Business – Google News https://www.fool.com/investing/2017/07/18/despite-falling-drug-sales-johnson-johnson-remains.aspx